Q6X-13297-90634 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Registered in v-safe
2020-12-21
Dose 1 — Pfizer-BioNTech
2020-12-21
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-28
Health check-in — day 7, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-04
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-03-22
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-04-12
Survey response — 3 months, dose 2
MedDRA: Fatigue, Hypertension, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Tachycardia, hypertension, fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-12
Survey response — 6 months, dose 2
MedDRA: Asthenia, Fatigue, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Tachycardia, weakness, extreme fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-12
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-15
Call 1 — Left Voicemail
2022-01-13
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Fair

Free text: Pregnancy

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 7 — 3 months, dose 2

2021-04-12

Symptoms: Tachycardia, hypertension, fatigue

Release 9 — 6 months, dose 2

2021-07-12

Symptoms: Tachycardia, weakness, extreme fatigue

Release 10 — 12 months, dose 2

2022-01-13

Symptoms: Pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthenia	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Hypertension	✓	✓	✓
SD	Pregnancy	·	·	✓
SD	Tachycardia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release